Women's conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
Access status:
Open Access
Type
ArticleAuthor/s
Tsuruda, Kaitlyn MVeierød, Marit B
Houssami, Nehmat
Waade, Gunvor G
Mangerud, Gunhild
Hofvind, Solveig
Abstract
Objective: To investigate conceptual knowledge about mammographic screening among Norwegian women.
Design: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia.
Setting: Our ...
See moreObjective: To investigate conceptual knowledge about mammographic screening among Norwegian women. Design: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. Setting: Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45-74 years. Participants: 2033 women completed our questionnaire. We excluded 13 women outside the target age range and 128 women with incomplete data. Responses from 1892 women were included in the final study sample. Primary and secondary outcome measures: The questionnaire focused on women's knowledge about the breast cancer mortality reduction, false positive results and overdiagnosis associated with mammographic screening. The primary outcome was the mean number of marks assigned in each of the three themes and overall. There were three potential marks for questions about breast cancer mortality, one for false positives and six for overdiagnosis. Results: Most women (91.7%) correctly reported that screened women are less likely to die of breast cancer than non-screened women. 39.7% of women reported having heard of a 'false positive screening result' and 86.2% identified the term's definition; 51.3% of women had heard of 'overdiagnosis' and 14.8% identified the term's definition. The mean score was 2.59 of 3 for questions about breast cancer mortality benefit and 0.93 of 1 for the question about false positive screening results. It was 2.23 of 6 for questions about overdiagnosis.
See less
See moreObjective: To investigate conceptual knowledge about mammographic screening among Norwegian women. Design: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. Setting: Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45-74 years. Participants: 2033 women completed our questionnaire. We excluded 13 women outside the target age range and 128 women with incomplete data. Responses from 1892 women were included in the final study sample. Primary and secondary outcome measures: The questionnaire focused on women's knowledge about the breast cancer mortality reduction, false positive results and overdiagnosis associated with mammographic screening. The primary outcome was the mean number of marks assigned in each of the three themes and overall. There were three potential marks for questions about breast cancer mortality, one for false positives and six for overdiagnosis. Results: Most women (91.7%) correctly reported that screened women are less likely to die of breast cancer than non-screened women. 39.7% of women reported having heard of a 'false positive screening result' and 86.2% identified the term's definition; 51.3% of women had heard of 'overdiagnosis' and 14.8% identified the term's definition. The mean score was 2.59 of 3 for questions about breast cancer mortality benefit and 0.93 of 1 for the question about false positive screening results. It was 2.23 of 6 for questions about overdiagnosis.
See less
Date
2022Source title
BMJ OpenVolume
11Issue
12Publisher
BMJ Publishing GroupLicence
Creative Commons Attribution-NonCommercial 4.0Faculty/School
Faculty of Medicine and Health, Sydney School of Public HealthShare